stella
beta
An Open Label Clinical Study to Evaluate Tanruprubart (Also Commonly Known as ANX005) in Participants With Guillain-Barré Syndrome (FORWARD Study) — Stella
Recruiting
Back to Guillain-Barre Syndrome trials
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations
(9 sites)
United States
HonorHealth Bob Bové Neuroscience Institute, Scottsdale, Arizona
Children's Hospital of Orange County, Orange, California
University of California Irvine, Orange, California
University of Colorado Hospital, Aurora, Colorado
Ochsner LSU Health, Shreveport, Louisiana
Show all 9 locations
View full record on ClinicalTrials.gov